Nucleosides from Phlebotomus papatasi Salivary Gland Ameliorate Murine Collagen-Induced Arthritis by Impairing Dendritic Cell Functions
Open Access
- 15 October 2011
- journal article
- research article
- Published by The American Association of Immunologists in The Journal of Immunology
- Vol. 187 (8), 4347-4359
- https://doi.org/10.4049/jimmunol.1003404
Abstract
Among several pharmacological compounds, Phlebotomine saliva contains substances with anti-inflammatory properties. In this article, we demonstrated the therapeutic activity of salivary gland extract (SGE) of Phlebotomus papatasi in an experimental model of arthritis (collagen-induced arthritis [CIA]) and identified the constituents responsible for such activity. Daily administration of SGE, initiated at disease onset, attenuated the severity of CIA, reducing the joint lesion and proinflammatory cytokine release. In vitro incubation of dendritic cells (DCs) with SGE limited specific CD4+ Th17 cell response. We identified adenosine (ADO) and 5′AMP as the major salivary molecules responsible for anti-inflammatory activities. Pharmacologic inhibition of ADO A2A receptor or enzymatic catabolism of salivary nucleosides reversed the SGE-induced immunosuppressive effect. Importantly, CD73 (ecto-5′-nucleotidase enzyme) is expressed on DC surface during stage of activation, suggesting that ADO is also generated by 5′AMP metabolism. Moreover, both nucleosides mimicked SGE-induced anti-inflammatory activity upon DC function in vitro and attenuated establishment of CIA in vivo. We reveal that ADO and 5′AMP are present in pharmacological amounts in P. papatasi saliva and act preferentially on DC function, consequently reducing Th17 subset activation and suppressing the autoimmune response. Thus, it is plausible that these constituents might be promising therapeutic molecules to target immune inflammatory diseases.This publication has 65 references indexed in Scilit:
- Therapeutic effect of tolerogenic dendritic cells in established collagen‐induced arthritis is associated with a reduction in Th17 responsesArthritis & Rheumatism, 2010
- Dendritic cells as targets for therapy in rheumatoid arthritisNature Reviews Rheumatology, 2009
- Plasticity of CD4+ FoxP3+ T cellsCurrent Opinion in Immunology, 2009
- The Immunomodulatory Action of Sialostatin L on Dendritic Cells Reveals Its Potential to Interfere with AutoimmunityPublished by The American Association of Immunologists ,2009
- Dendritic cells modulated by innate immunity improve collagen‐induced arthritis and induce regulatory T cells in vivoImmunology, 2008
- Adenosine receptors in regulation of dendritic cell differentiation and functionBlood, 2008
- Rheumatoid Arthritis Synovium Contains Two Subsets of CD83−DC-LAMP− Dendritic Cells with Distinct Cytokine ProfilesThe American Journal of Pathology, 2008
- Phlebotomine salivas inhibit immune inflammation-induced neutrophil migration via an autocrine DC-derived PGE2/IL-10 sequential pathwayJournal of Leukocyte Biology, 2008
- Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppressionThe Journal of Experimental Medicine, 2007
- Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritisAnnals Of The Rheumatic Diseases, 2006